Perfil
Lisa Sinclair is Senior Vice President-Corporate Operations at Arvinas, Inc. since 2022.
Formerly, Ms. Sinclair was VP-Global R&D Portfolio & Performance at AstraZeneca, Inc., Head-Programs & Alliance Management at Springworks Therapeutics, Inc., and Head-Corporate & Commercial Strategy at Rallybio Corp.
Education includes undergraduate studies at the University of Vermont.
Cargos activos de Lisa Sinclair
| Empresas | Cargo | Inicio |
|---|---|---|
| ARVINAS, INC. | Director de Operaciones | 15/08/2022 |
Antiguos cargos conocidos de Lisa Sinclair.
| Empresas | Cargo | Fin |
|---|---|---|
| SPRINGWORKS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Corporate Officer/Principal | - |
| RALLYBIO CORPORATION | Corporate Officer/Principal | - |
Formación de Lisa Sinclair.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
University of Vermont
University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
Arvinas, Inc.
Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Springworks Therapeutics, Inc.
Springworks Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes medicines for nervous system disorders | Health Technology |
Rallybio Corp.
Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
- Bolsa de valores
- Insiders
- Lisa Sinclair
















